Pre‐diagnostic blood immune markers, incidence and progression of B‐cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses-Reference-Cited by-同舟云学术

Pre‐diagnostic blood immune markers, incidence and progression of B‐cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses

Published:2018-04-26 Issue:6 Volume:143 Page:1335-1347
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Vermeulen Roel¹²,Saberi Hosnijeh Fatemeh¹³^ORCID,Bodinier Barbara²,Portengen Lützen¹,Liquet Benoît⁴⁵,Garrido‐Manriquez Javiera²,Lokhorst Henk⁶,Bergdahl Ingvar A.⁷,Kyrtopoulos Soterios A.⁸,Johansson Ann‐Sofie⁹,Georgiadis Panagiotis⁸,Melin Beatrice⁹,Palli Domenico¹⁰^ORCID,Krogh Vittorio¹¹^ORCID,Panico Salvatore¹²,Sacerdote Carlotta¹³^ORCID,Tumino Rosario¹⁴,Vineis Paolo²¹⁵,Castagné Raphaële²¹⁶^ORCID,Chadeau‐Hyam Marc¹²,Botsivali Maria¹⁷,Chatziioannou Aristotelis¹⁷,Valavanis Ioannis¹⁷,Kleinjans Jos C.S.¹⁸,de Kok Theo M.C.M.¹⁸,Keun Hector C.¹⁹,Athersuch Toby J.²²⁰,Kelly Rachel³²¹,Lenner Per⁹,Hallmans Goran²²,Stephanou Euripides G.²³,Myridakis Antonis²³,Kogevinas Manolis²⁴,Fazzo Lucia²⁵,De Santis Marco²⁵,Comba Pietro²⁵,Bendinelli Benedetta¹⁰,Kiviranta Hannu²⁶,Rantakokko Panu²⁶,Airaksinen Riikka²⁶,Ruokojarvi Paivi²⁶,Gilthorpe Mark²⁷,Fleming Sarah²⁷,Fleming Thomas²⁷,Tu Yu‐Kang²⁷,Lundh Thomas²⁸,Chien Kuo‐Liong²⁹,Chen Wei J.²⁹,Lee Wen‐Chung²⁹,Kate Hsiao Chuhsing²⁹,Kuo Po‐Hsiu²⁹,Hung Hung²⁹,Liao Shu‐Fen²⁹,

Affiliation:

1. Division of Environmental EpidemiologyUtrecht University, Institute for Risk Assessment SciencesUtrecht The Netherlands

2. MRC‐PHE Centre for Environment and Health, Department of Epidemiology and BiostatisticsImperial College LondonLondon United Kingdom

3. Immunology DepartmentErasmus University Medical CenterRotterdam The Netherlands

4. Laboratoire de Mathématiques et de leurs ApplicationsUniversité de Pau et des Pays de l'Adour, UMR CNRSPau France

5. ARC Centre of Excellence for Mathematical and Statistical FrontiersQueensland University of Technology (QUT)Brisbane Australia

6. Department of HematologyUniversity Medical Center UtrechtUtrecht The Netherlands

7. Department of Public Health and Clinical Medicine, and Department of Biobank ResearchUmeå UniversityUmeå Sweden

8. National Hellenic Research FoundationInstitute of Biology, Medicinal Chemistry and BiotechnologyAthens Greece

9. Department of Radiation SciencesOncology, Umeå UniversityUmeå Sweden

10. The Institute for Cancer Research and PreventionFlorence Italy

11. Fondazione IRCCS–Instituto Nazionale dei TumoriMilan Italy

12. Department of Clinical Medicine and SurgeryUniversity of Naples Frederico IINaples Italy

13. Piedmont Reference Centre for Epidemiology and Cancer Prevention (CPO Piemonte)Turin Italy

14. Cancer registry and Histopathology UnitAzienda Ospedaliera ‘Civile–M.P.Arezzo’Ragusa Italy

15. HuGeF FoundationTorino Italy

16. INSERM, UMR1027, Université Toulouse III‐Paul SabatierToulouse France

17. Institute of Biology, Medicinal Chemistry and BiotechnologyNational Hellenic Research FoundationAthens Greece

18. Department of ToxicogenomicsMaastricht UniversityMaastricht The Netherlands

19. Division of Cancer, Department of Surgery and CancerImperial College London, Institute of Reproductive and Developmental Biology (IRDB), Hammersmith HospitalLondon United Kingdom

20. Division of Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of MedicineImperial College LondonLondon United Kingdom

21. Channing Division of Network Medicine, Department of MedicineBrigham and Women's Hospital and Harvard Medical SchoolBoston USA

22. Nutrition Research, Department of Public Health and Clinical Medicine, and Department of Biobank ResearchUmeå UniversityUmeå Sweden

23. Environmental Chemical Processes LaboratoryUniversity of CreteHeraklion Greece

24. ISGlobalCentre for Research in Environmental Epidemiology (CREAL)Barcelona Spain

25. Istituto Superiore di SanitaRome Italy

26. National Institute for Health and WelfareKuopio Finland

27. University of LeedsLeeds United Kingdom

28. Lund UniversityLund Sweden

29. National Taiwan UniversityTaipei Taiwan

Funder

Cancer Research-UK ‘Mechanomics’ Population Research Committee project grant

FP7 project Envirogenomarkers

Fondation pour la Recherche Médicale (FRM)

Becas Chile scholarship scheme from the Chilean Government

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31536

Reference50 articles.

1. Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology

2. JaffeES HarrisNL SteinH et al. World health organization classification of tumours: pathology and genetics of tumours of hematopoietic and lymphoid tissues. International Agency for Research on Cancer 2001.

3. Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

4. Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts

5. Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated calibration for stability selection in penalised regression and graphical models;Journal of the Royal Statistical Society Series C: Applied Statistics;2023-07-13

2. Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes;Cancer Epidemiology, Biomarkers & Prevention;2022-11-21

3. Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis;International Journal of Molecular Sciences;2021-07-13

4. Immunological Prognostic Factors in Multiple Myeloma;International Journal of Molecular Sciences;2021-03-30

5. Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer;Cancer Research;2021-02-11